Eli Lilly on Friday crossed the $1 trillion market-cap threshold, becoming the first drugmaker to ever reach that milestone.

New GLP-1 weight-loss drugs may preserve muscle, protect skin, and reduce the risk of "Ozempic face." Experts explain what ...

NBC News' Anne Thompson joins "Here's the Scoop" co-host Yasmin Vossoughian to talk about why some people are microdosing GLP ...

Studies from Novo Nordisk due early next month will give the strongest indication yet of whether blockbuster GLP-1 drugs - a ...

Absent tools such as rebate reform, transparent pricing or accelerated biosimilar substitution, true price competition will ...

Novo Nordisk A/S faces intensifying GLP-1 competition, notably from Eli Lilly, prompting price cuts for Wegovy. Learn more ...

Your gut changes on GLP-1s — but you don’t have to feel miserable. These 23 probiotics smooth digestion, calm bloating, and ...

“In general, we tend to see more weight loss with GLP-1-based medication treatment in patients who are female, those who do ...

Drama Llama is part of a new generation of sexist marketing, encouraging women to minimize serious GLP-1 side effects and get ...

Tirzepatide, semaglutide, and liraglutide lead to weight loss in adults with obesity and T1D over 1 year; the greatest weight ...

Purchases of food and beverage products high in carbohydrates and sugar are decreasing among GLP-1 users, who are “actively ...

CivicScience engages directly with consumers, collecting over one million survey responses daily, to turn real-time insights ...